TRANDATE Drug Patent Profile
✉ Email this page to a colleague
When do Trandate patents expire, and what generic alternatives are available?
Trandate is a drug marketed by Sebela Ireland Ltd, Alvogen, and Glaxosmithkline. and is included in three NDAs.
The generic ingredient in TRANDATE is hydrochlorothiazide; labetalol hydrochloride. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; labetalol hydrochloride profile page.
Summary for TRANDATE
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 74 |
Clinical Trials: | 10 |
Patent Applications: | 4,301 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in TRANDATE? | TRANDATE excipients list |
DailyMed Link: | TRANDATE at DailyMed |
Recent Clinical Trials for TRANDATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Loma Linda University | N/A |
Nebraska Methodist Health System | Phase 4 |
Wright State University | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for TRANDATE
US Patents and Regulatory Information for TRANDATE
Expired US Patents for TRANDATE
International Patents for TRANDATE
See the table below for patents covering TRANDATE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Sweden | 372935 | ⤷ Try a Trial | |
Belgium | 704037 | ⤷ Try a Trial | |
Netherlands | 7811843 | ⤷ Try a Trial | |
Belgium | 752892 | ⤷ Try a Trial | |
Germany | 2032642 | 1-PHENYL-2-AMINOAETHANOL-DERIVATE, VERFAHREN ZU IHRER HERSTELLUNG UND DIESE VERBINDUNGEN ENTHALTENDE ARZNEIMITTEL | ⤷ Try a Trial |
Canada | 932734 | PHENYLAMINOETHANOL DERIVATIVES | ⤷ Try a Trial |
Malaysia | 7400003 | PHENYLAMINOETHANOL DERIVATIVES | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |